LASSBio-1632

• Target:

  PDE|||Others

• Related Pathways:

  Metabolism|||Others

• Bioactivity:

  LASSBio-1632 is a novel anti-asthmatic lead candidate that selectively inhibits PDE4A and PDE4D isoenzymes, leading to the suppression of airway hyper-reactivity (AHR) and TNF-? production in lung tissue. With high experimental BBB permeability, LASSBio-1632 (7j) efficiently crosses the blood-brain barrier through passive diffusion [1].

• Molecular Formula:

  C18H20N2O6S

• Molecular Weight:

  392.43

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C